NASDAQ:JYNT - Nasdaq - US47973J1025 - Common Stock - Currency: USD
9.9
-0.59 (-5.67%)
The current stock price of JYNT is 9.9 USD. In the past month the price decreased by -7.48%. In the past year, price decreased by -39.78%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 15.43 | 86.02B | ||
THC | TENET HEALTHCARE CORP | 11.43 | 13.84B | ||
EHC | ENCOMPASS HEALTH CORP | 24.85 | 11.71B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 10.02 | 11.62B | ||
ENSG | ENSIGN GROUP INC/THE | 23.04 | 7.58B | ||
SGRY | SURGERY PARTNERS INC | 24.97 | 3.01B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 9.51 | 2.77B | ||
ACHC | ACADIA HEALTHCARE CO INC | 6.91 | 2.10B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 11.01 | 1.90B | ||
ARDT | ARDENT HEALTH PARTNERS INC | 8.78 | 1.88B | ||
PACS | PACS GROUP INC | 13.26 | 1.56B | ||
NHC | NATIONAL HEALTHCARE CORP | 14.39 | 1.45B |
The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. The company is headquartered in Scottsdale, Arizona and currently employs 443 full-time employees. The company went IPO on 2014-11-11. The firm operates the Franchise Operations segment. The firm and its franchisees provide management services to affiliated professional chiropractic practices. The franchise system consists of approximately 842 clinics in operation. The company offers a range of membership and wellness packages. The company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
JOINT CORP/THE
16767 N Perimeter Drive, Suite 240
Scottsdale ARIZONA 85260 US
CEO: Peter D. Holt
Employees: 590
Phone: 14802455960
The current stock price of JYNT is 9.9 USD. The price decreased by -5.67% in the last trading session.
The exchange symbol of JOINT CORP/THE is JYNT and it is listed on the Nasdaq exchange.
JYNT stock is listed on the Nasdaq exchange.
11 analysts have analysed JYNT and the average price target is 16.7 USD. This implies a price increase of 68.71% is expected in the next year compared to the current price of 9.9. Check the JOINT CORP/THE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
JOINT CORP/THE (JYNT) has a market capitalization of 151.67M USD. This makes JYNT a Micro Cap stock.
JOINT CORP/THE (JYNT) currently has 590 employees.
JOINT CORP/THE (JYNT) has a support level at 9.89 and a resistance level at 10.5. Check the full technical report for a detailed analysis of JYNT support and resistance levels.
The Revenue of JOINT CORP/THE (JYNT) is expected to decline by -52.66% in the next year. Check the estimates tab for more information on the JYNT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
JYNT does not pay a dividend.
JOINT CORP/THE (JYNT) will report earnings on 2025-05-08, after the market close.
JOINT CORP/THE (JYNT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).
The outstanding short interest for JOINT CORP/THE (JYNT) is 2.84% of its float. Check the ownership tab for more information on the JYNT short interest.
ChartMill assigns a fundamental rating of 3 / 10 to JYNT. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months JYNT reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS increased by 66.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -17.84% | ||
ROE | -80.05% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 78% to JYNT. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 153.32% and a revenue growth -52.66% for JYNT